From each FDA label
Do GLP-1s cause UTIs or yeast infections?
No current GLP-1 label prints a rate for urinary or yeast infections in its main trial table.
Not from trials
Reports to FDA about urinary or yeast infections
Counts of voluntary reports from patients and doctors. They cannot show that a medicine caused anything and cannot give a rate, and a brand used by more people draws more reports.
| Medicine | Reports naming | All reports on it |
|---|---|---|
| Ozempic | Urinary tract infection: 738 · Fungal infection: 190 · Candida infection: 37 · Vulvovaginal mycotic infection: 28 | 70,863 |
| Trulicity | Urinary tract infection: 499 · Fungal infection: 259 · Vulvovaginal mycotic infection: 25 · Candida infection: 17 | 87,279 |
| Mounjaro | Urinary tract infection: 394 · Fungal infection: 94 · Candida infection: 25 | 97,440 |
| Victoza | Urinary tract infection: 354 · Fungal infection: 143 · Vulvovaginal mycotic infection: 19 · Candida infection: 17 | 41,462 |
| Byetta | Urinary tract infection: 326 · Fungal infection: 90 · Vulvovaginal mycotic infection: 14 | 52,087 |
| Wegovy | Urinary tract infection: 140 · Fungal infection: 14 · Candida infection: 11 | 25,993 |
| Zepbound | Urinary tract infection: 131 · Fungal infection: 18 · Candida infection: 13 · Vulvovaginal mycotic infection: 6 | 80,835 |
| Rybelsus and Ozempic tablets | Urinary tract infection: 96 · Fungal infection: 25 · Candida infection: 6 | 7,758 |
| Saxenda | Urinary tract infection: 45 · Fungal infection: 9 · Candida infection: 2 | 7,270 |
| Foundayo | Urinary tract infection: 5 · Candida infection: 1 · Fungal infection: 1 | 3,050 |
Counted through openFDA from FDA's Adverse Event Reporting System, refreshed weekly. One report can name several terms.
Updated automatically
Latest FDA label updates
- FDA labelFDA label updated: Zepbound (Eli Lilly and Company), effective 2026-08-28
- FDA labelFDA label updated: Mounjaro (Eli Lilly and Company), effective 2026-08-27
- FDA labelFDA label updated: Foundayo (Eli Lilly and Company), effective 2026-07-29
- FDA labelFDA label updated: Liraglutide (Meitheal Pharmaceuticals Inc.), effective 2026-07-27
- FDA labelFDA label updated: Liraglutide (NorthStar Rx LLC), effective 2026-06-24
Written from each source's own record as it changes. Every change on GLPcompare
Other side effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Indigestion
- Acid reflux
- Burping
- Gas
- Bloating
- Fatigue
- Headache
- Dizziness
- Hair loss
- Injection site reactions
- Skin sensitivity and tingling
- Taste changes
- Muscle loss
- Joint pain
- Insomnia
- Kidney stones
- Rash and itching
- Low blood pressure
- Anxiety
- Bone loss
- Jaw pain and clenching
- Body aches
- Pancreatitis
- Gallbladder problems
- Low blood sugar
- Kidney problems
- Gastroparesis and severe stomach problems
- Allergic reactions
- Thyroid cancer
- Eye problems
- Fast heart rate
- Aspiration under anesthesia
- Depression and suicidal thoughts
- Birth control
- Drug interactions
- Taking two GLP-1s
- Metformin
- Pregnancy
- Breastfeeding
Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.